Understanding the United States COPD Patient Experience in 2024: Demographics, Impact on Quality of Life, Information-seeking Behaviors, HCP Engagement, treatment Awareness and Experiences Dublin, Oct. 24, 2024 (GLOBE NEWSWIRE) -- The "COPD in the United States: Understanding the COPD Patient Experience" report has been added to ResearchAndMarkets.com's offering. This report...

U.S. COPD Treatment Awareness & Satisfaction Report 2023-2024: Understand HCP Treatment Discussions, Treatment Satisfaction & Awareness, Clinical Trial Interest, and Much More Dublin, Sept. 26, 2024 (GLOBE NEWSWIRE) -- The "COPD in the United States: A Review of 2023 - Key Insights into Treatment Awareness & Satisfaction" report has been added to ...

Alpha-1 Antitrypsin Deficiency Market and Epidemiology Forecast to 2032 Dublin, May 21, 2024 (GLOBE NEWSWIRE) -- The "Alpha-1 Antitrypsin Deficiency Market Insight, Epidemiology and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offeringA...

Alpha-1 Antitrypsin Deficiency Market Research Report 2022: Unmet Needs and Opportunities, Treatment Options, Pipeline Assessment, R&D Strategies, Outlook Dublin, June 10, 2022 (GLOBE NEWSWIRE) -- The "Alpha-1 Antitrypsin Deficiency Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical...